Influence of donor specific HLA antibodies detected by Luminex in kidney graft survival: A multivariate analysis

Human Immunology

Volumn 74, Issue 5, 2013, Pages 545-549

  Caro Oleas, J L ^a   Gonzalez Escribano M F ^a   Gentil Govantes, M A ^b   Acevedo, M J ^a   Gonzalez Roncero F M ^b   Bernal Blanco, G ^b   Nunez Roldan A ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ANTIBODY SCREENING; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GRAFT FAILURE; GRAFT SURVIVAL; HLA TYPING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; RISK FACTOR; T LYMPHOCYTE;

ADULT; AGED; ANTIBODIES; FEMALE; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; IMMUNOLOGIC TECHNIQUES; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS; TISSUE DONORS;

EID: 84876316640     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2013.01.010     Document Type: Article

References (27)

1. Bingaman A., Murphey C., Palma-Vargas J., Wright F. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008, 86:1864-1868.
2. Vaidya S., Partlow D., Susskind B., Noor M., Barnes T., Gugliuzza K. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006, 82:1524-1528.
3. Vaidya S. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches. Transplantation 2008, 85:1046-1050.
4. Gupta A., Iveson V., Varagunam M., Bodger S., Sinnott P., Thuraisingham R.C. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplant: are they relevant?. Transplantation 2008, 85:1081-1082.
5. van den Berg-Loonen E.M., Billen E.V., Voorter C.E., et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008, 85:1086-1090.
6. Aubert V., Venetz J.P., Pantaleo G., Pascual M. Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant?. Transplantation 2009, 87:1897-1898.
7. Gupta A., Sinnott P. Clinical relevance of pretransplant human leukocyte antigen donor-specific antibodies renal in renal patients waiting for a transplant: a risk factor. Hum Immunol 2009, 70:618-622.
8. Singh N., Djamali A., Lorentzen D., et al. Pretransplant donor-specific antibodies detected by single-antigen bead flow cytometry are associated with inferior kidney transplant outcomes. Transplantation 2010, 90:1079-1084.
9. Süsal C., Döhler B., Opelz G. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a collaborative transplant study report. Hum Immunol 2009, 70:569-573.
10. Süsal C., Ovens J., Mahmoud K., et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a collaborative transplant study report. Transplantation 2011, 91:883-887.
11. Caro-Oleas J.L., González-Escribano M.F., González-Roncero F.M., et al. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Nephrol Dial Transplant 2012, 27:1231-1238.
12. Lefaucheur C., Loupy A., Hill G.S., et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010, 21:1398-1406.
13. Amico P., Hönger G., Mayr M., Steiger J., Hopfer H., Schaub S. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single antigen flow-beads. Transplantation 2009, 87:1681-1688.
14. Quiroga I., McShane P., Koo D.D., et al. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant 2006, 21:1689-1696.
15. Morris P.J., Johnson R.J., Fuggle S.V., Belger M.A., Briggs J.D. Analysis of factors that affect outcome of primary cadaveric renal transplantation in the UK. HLA task force of the kidney advisory group of the United Kingdom Transplant Support Service Authority (UKTSSA). Lancet 1999, 354:1147-1152.
16. Busson M., Prevost P., Bignon J.D., et al. Multifactorial analysis of the outcome of 6430 cadaver kidney grafts. Transplant Int 1992, 5:162-164.
17. Poli F., Scalamogna M., Cardillo M., Porta E., Sirchia G. An algorithm for cadaver kidney allocation based on a multivariate analysis of factors impacting on cadaver kidney graft survival and function. Transplant Int 2000, 13(S1):259-262.
18. Nicholson M.L., Metcalfe M.S., White S.A., et al. A comparison of the results of renal transplantation from non-heart-beating, conventional cadaveric and living donors. Kidney Int 2000, 58:2585-2591.
19. Verran D.J., deLeon C., Chui A.K., Hapman J.R. Factors in older cadaveric organ donors impacting on renal allograft outcome. Clin Transplant 2001, 15:1-5.
20. Sanfilippo F., Vaughn W.K., LeFor W.M., Spees E.K. Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation 1986, 42:28-34.
21. Tesi R.J., Elkhammas E.A., Davies E.A., Henry M.L., Ferguson R.M. Renal transplantation in older people. Lancet 1994, 343:461-464.
22. Fabrizi F., Martin P., Dixit V., Bunnapradist S., Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant 2005, 5:1452-1461.
23. Opelz G., Wujciak T., Döhler B., Scherer S., Mytilineos J. HLA compatibility and organ transplant survival. collaborative transplant study. Rev Immunogenet 1999, 1:334-342.
24. Remport A., Keszei A., Panna-Vamos E., et al. Association of pre-transplant dialysis duration with outcome in kidney transplant recipients: a prevalent cohort study. Int Urol Nephrol 2011, 43:215-224.
25. Lezaic V., Naumovic R., Marinkovic J., Jaksic E., Djukanovic L. Donor kidney glomerular filtration rate and post transplant graft function. Am J Transplant 2004, 4:1669-1674.
26. Cruzado J.M., Torras J., Gil-Vernet S., Grinyó J.M. Glomerulonephritis associated with hepatitis C virus infection after renal transplantation. Nephrol Dial Transplant 2000, 15(S8):65-67.
27. Morales J.M., Marcén R., Andres A., et al. Renal transplantation in patients with hepatitis C virus antibody. A long national experience. NDT Plus 2010, 3(S2):41-46.